CYTOKINETICS, INCORPORATED Basic Shares Outstanding (Weighted Average)
CYTOKINETICS, INCORPORATED (CYTK) reported Basic Shares Outstanding (Weighted Average) of 132.09 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 132.09K shares, a 10.57% increase year-over-year.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 123.27K shares, a 4.03% increase year-over-year.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 122.46K shares, a 3.68% increase year-over-year.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 119.98K shares, a 1.95% increase year-over-year.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for fiscal 2025 was 120.10K shares, a 7.25% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for fiscal 2024 was 111.98K shares, a 16.01% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for fiscal 2023 was 96.52K shares, a 7.46% increase from fiscal 2022.
- CYTOKINETICS, INCORPORATED weighted average number of shares outstanding, basic for fiscal 2022 was 89.83K shares, a 16.83% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 132.09K shares 10-Q · filed 2026-08-06 | 127.70K shares 10-Q · filed 2026-08-06 | 125.94K shares derived: average of 3 quarters · filed 2026-08-06 | 124.45K shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 123.27K shares 10-Q · filed 2026-05-05 | 122.87K shares derived: average of 2 quarters · filed 2026-05-05 | 121.91K shares derived: average of 3 quarters · filed 2026-05-05 | 121.29K shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | 122.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 121.22K shares derived: average of 2 quarters · filed 2026-02-26 | 120.63K shares derived: average of 3 quarters · filed 2026-08-06 | 120.10K shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 119.98K shares 10-Q · filed 2025-11-05 | 119.72K shares derived: average of 2 quarters · filed 2026-08-06 | 119.32K shares 10-Q · filed 2025-11-05 | 119.01K shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | 119.46K shares 10-Q · filed 2026-08-06 | 118.98K shares 10-Q · filed 2026-08-06 | 118.69K shares derived: average of 3 quarters · filed 2026-08-06 | 118.44K shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | 118.50K shares 10-Q · filed 2026-05-05 | 118.31K shares derived: average of 2 quarters · filed 2026-05-05 | 118.10K shares derived: average of 3 quarters · filed 2026-05-05 | 115.89K shares derived: average of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | 118.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 117.90K shares derived: average of 2 quarters · filed 2026-02-26 | 115.02K shares derived: average of 3 quarters · filed 2026-02-26 | 111.98K shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 117.69K shares 10-Q · filed 2025-11-05 | 113.46K shares derived: average of 2 quarters · filed 2025-11-05 | 109.93K shares 10-Q · filed 2025-11-05 | 106.99K shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | 109.24K shares 10-Q · filed 2025-08-07 | 106.01K shares 10-Q · filed 2025-08-07 | 103.42K shares derived: average of 3 quarters · filed 2026-02-26 | 101.58K shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | 101.92K shares 10-Q · filed 2025-05-06 | 100.51K shares derived: average of 2 quarters · filed 2026-02-26 | 99.03K shares derived: average of 3 quarters · filed 2026-02-26 | 98.21K shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | 99.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 97.58K shares derived: average of 2 quarters · filed 2026-02-26 | 96.97K shares derived: average of 3 quarters · filed 2026-02-26 | 96.52K shares 10-K · filed 2026-02-26 | |
| 2023-09-30 | 96.07K shares 10-Q · filed 2024-11-07 | 95.91K shares derived: average of 2 quarters · filed 2024-11-07 | 95.67K shares 10-Q · filed 2024-11-07 | 95.43K shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | 95.75K shares 10-Q · filed 2024-08-09 | 95.46K shares 10-Q · filed 2024-08-09 | 95.21K shares derived: average of 3 quarters · filed 2025-02-27 | 94.85K shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | 95.16K shares 10-Q · filed 2024-05-10 | 94.94K shares derived: average of 2 quarters · filed 2025-02-27 | 94.55K shares derived: average of 3 quarters · filed 2025-02-27 | 92.34K shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | 94.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 94.24K shares derived: average of 2 quarters · filed 2025-02-27 | 91.40K shares derived: average of 3 quarters · filed 2025-02-27 | 89.83K shares 10-K · filed 2025-02-27 | |
| 2022-09-30 | 93.76K shares 10-Q · filed 2023-11-03 | 89.74K shares derived: average of 2 quarters · filed 2023-11-03 | 88.19K shares 10-Q · filed 2023-11-03 | 87.16K shares derived: average of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | 85.73K shares 10-Q · filed 2023-08-03 | 85.37K shares 10-Q · filed 2023-08-03 | 84.96K shares derived: average of 3 quarters · filed 2024-02-28 | 83.81K shares derived: average of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | 85.00K shares 10-Q · filed 2023-05-05 | 84.58K shares derived: average of 2 quarters · filed 2024-02-28 | 83.16K shares derived: average of 3 quarters · filed 2024-02-28 | 80.31K shares derived: average of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | 84.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 82.25K shares derived: average of 2 quarters · filed 2024-02-28 | 78.75K shares derived: average of 3 quarters · filed 2024-02-28 | 76.89K shares 10-K · filed 2024-02-28 | |
| 2021-09-30 | 80.33K shares 10-Q · filed 2022-11-04 | 76.04K shares derived: average of 2 quarters · filed 2022-11-04 | 74.46K shares 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | 71.75K shares 10-Q · filed 2022-08-05 | 71.48K shares 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | 64.52K shares 10-K · filed 2023-03-01 | ||||
| 2017-12-31 | 53.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 53.85M shares derived: average of 2 quarters · filed 2018-03-05 | 49.40M shares 10-K · filed 2018-03-05 | ||
| 2017-09-30 | 53.72M shares 10-Q · filed 2017-11-03 | 47.88M shares 10-Q · filed 2017-11-03 | |||
| 2016-12-31 | 40.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 40.26M shares derived: average of 2 quarters · filed 2018-03-05 | 39.94M shares 10-K · filed 2018-03-05 | ||
| 2016-09-30 | 39.93M shares 10-Q · filed 2017-11-03 | 39.73M shares 10-Q · filed 2017-11-03 | |||
| 2015-12-31 | 39.10M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | 38.93M shares derived: average of 2 quarters · filed 2018-03-05 | 38.81M shares 10-K · filed 2018-03-05 | ||
| 2015-09-30 | 38.75M shares 10-Q/A · filed 2016-12-15 | 38.72M shares 10-Q/A · filed 2016-12-15 | |||
| 2014-12-31 | 35.71M shares 10-K · filed 2017-03-06 | ||||
| 2012-12-31 | 108.64M shares 10-K · filed 2013-03-15 | ||||
| 2011-12-31 | 70.80M shares 10-K · filed 2013-03-15 | ||||
| 2010-12-31 | 64.29M shares 10-K · filed 2013-03-15 | 64.17M shares 10-K · filed 2012-03-13 | |||
| 2009-12-31 | 57.39M shares 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |